1. 65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicine
    Lois M Mulligan, 2018, Endocrine-Related Cancer CrossRef
  2. Selective Antitumor Activity of Datelliptium toward Medullary Thyroid Carcinoma by Downregulating RET Transcriptional Activity
    Tariq Alqahtani et al, 2021, Cancers CrossRef
  3. Promising Role of Alkaloids in the Prevention and Treatment of Thyroid Cancer and Autoimmune Thyroid Disease: A Comprehensive Review of the Current Evidence
    Giulia Di Dalmazi et al, 2024, International Journal of Molecular Sciences CrossRef
  4. Salinomycin and its derivatives as potent RET transcriptional inhibitors for the treatment of medullary thyroid carcinoma
    Tariq Alqahtani et al, 2019, International Journal of Oncology CrossRef
  5. Developing Novel G-Quadruplex Ligands: from Interaction with Nucleic Acids to Interfering with Nucleic Acid–Protein Interaction
    Zhi-Yin Sun et al, 2019, Molecules CrossRef
  6. Berberine as a Potential Anticancer Agent: A Comprehensive Review
    Abdur Rauf et al, 2021, Molecules CrossRef
  7. Bioactivities and Action Mechanisms of Ellipticine Derivatives Reported Prior to 2023
    Wen Hou et al, 2024, Chemistry & Biodiversity CrossRef
  8. Novel targeted therapeutics for MEN2
    Sara Redaelli et al, 2018, Endocrine-Related Cancer CrossRef
  9. G-quadruplex DNA: a novel target for drug design
    Fang-Yuan Teng et al, 2021, Cellular and Molecular Life Sciences CrossRef
  10. Crosstalk between G-quadruplex and ROS
    Songjiang Wu et al, 2023, Cell Death & Disease CrossRef
  11. G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting
    Francesca Romano et al, 2023, Expert Opinion on Therapeutic Patents CrossRef
  12. Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes
    Tariq Alqahtani et al, 2023, Cancers CrossRef
  13. Scaffolds in cytotoxic drugs and novel antitumor molecules interacting with nucleic acids
    Tian-Miao Ou et al, 2023, Privileged Scaffolds in Drug Discovery CrossRef